RIANLON CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.4 CNY | +1.74% |
|
-3.08% | +12.99% |
| 26/04 | Rianlon Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 17/04 | Rianlon Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 62% by 2026.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +12.99% | 1.06B | - | ||
| +5.92% | 105B | A- | ||
| -4.43% | 63.83B | A- | ||
| +60.48% | 45.28B | B | ||
| +16.73% | 38.93B | B | ||
| +6.77% | 33.06B | A- | ||
| +12.31% | 20.21B | B- | ||
| +13.41% | 16.94B | C+ | ||
| +25.44% | 16.08B | B- | ||
| +5.80% | 14.49B | B |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 300596 Stock
- Ratings Rianlon Corporation